Saturday, September 19, 2020 2:06:30 PM
I'm trying to look at this objectively though. Currently it's being treated as a pump and dump by some. That much is obvious, as the company hasn't released any news on business deals or the like. But I am also dubious to the claims of the CEO being a liar and a scoundrel. That's unfounded opinion, as far as I can tell.
I think that the company itself has potential though, and in the end, no amount of pumping or bashing will make a difference if they're legit (and to me, there is nothing that proves they aren't).
You might have seen that they recently won their court case. This, in my eyes marks a new beginning. Why would they want to draw negative attention to themselves by doing anything underhanded? You can bet that those who filed the lawsuit are watching DarkPulse like hyenas, waiting to pounce on the slightest slip up. DarkPulse is on the radar because they've been to court, so I think this would be incentive for Mr. O'Leary & Co to not give anyone an excuse to make a complaint. They're going to do things by the book.
They've made recent management and board changes as well, which is also indicative of a fresh start. They weeded out those who were holding them back, and now they have room to grow.
Lastly, they have a product of value which just received export control classification from the Bureau of Industry and Security. Now that the shenanigans are behind them, they can now focus on making business deals. The company is very active on Twitter, and their posts prove that there is a need for BOTDA sensors.
All this being said, I am not an expert. I am just saying it how I see it. This is a young company, and given time, I think there will be growth. These are my reasons for investing.
Thank you for listening to my Ted Talk.
Recent DPLS News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/09/2024 03:56:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 09:25:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 07:14:41 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 12/18/2023 09:39:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2023 08:18:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 05:00:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/15/2023 10:16:05 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 05:55:23 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/14/2023 05:15:11 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 11/07/2023 09:29:36 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 10/20/2023 09:17:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2023 12:04:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2023 07:51:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/22/2023 08:41:26 PM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 08/31/2023 09:19:17 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:32:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 05:01:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/03/2023 08:10:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 06:32:59 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/18/2023 09:16:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2023 08:05:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/06/2023 06:21:32 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM